{
    "name": "naloxone intranasal",
    "comment": "Rx, OTC",
    "other_names": [
        "Narcan Nasal Spray",
        "Kloxxado"
    ],
    "classes": [
        "Opioid Reversal Agents"
    ],
    "source": "https://reference.medscape.com/drug/narcan-nasal-spray-kloxxado-naloxone-intranasal-1000057",
    "pregnancy": {
        "common": [
            "Limited available data are insufficient on use in pregnant females to inform a drug-associated risk regarding teratogenicity"
        ],
        "specific": [
            {
                "type": "Fetal/neonatal adverse reactions",
                "description": [
                    "Crosses the placenta and may precipitate withdrawal in the fetus, as well as in the opioid-dependent mother",
                    "Evaluate fetus for signs of distress after naloxone is used",
                    "Careful monitoring is needed until the fetus and mother are stabilized"
                ]
            },
            {
                "type": "Animal studies",
                "description": [
                    "No embryotoxic or teratogenic effects were observed in mice and rats treated during the period of organogenesis at doses equivalent to 6-12 times a human dose of 8 mg/day"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Unknown if distributed in human breast milk",
            "Studies in nursing mothers have shown that naloxone does not affect prolactin or oxytocin hormone levels",
            "Minimally orally bioavailable and is unlikely to affect breastfed infants"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Risk of recurrent respiratory and CNS depression",
                    "description": [
                        "There is limited data to inform if 2 mg dose will avoid precipitation of severe opioid withdrawal in setting of opioid dependence; however, the 2 mg dose may not provide adequate and timely reversal in persons who may be exposed to overdose of potent or very high dose of opioids",
                        "Risk of recurrent respiratory and CNS depression exists because the duration of action of most opioids may exceed that of naloxone nasal spray",
                        "Seek immediate emergency medical assistance following the first dose",
                        "Administer additional doses and additional supportive and/or resuscitative measures while waiting for help "
                    ]
                },
                {
                    "type": "Reversing partial opioid agonists or mixed opioid agonist/antagonists",
                    "description": [
                        "Incomplete reversal of respiratory depression may be observed when attempting to reverse partial opioid agonists or mixed opioid agonist/antagonists",
                        "Larger or repeat doses may be required to antagonize buprenorphine because the latter has a long duration of action owing to its slow rate of binding and subsequent slow dissociation from the opioid receptor "
                    ]
                },
                {
                    "type": "Precipitation of severe opioid withdrawal",
                    "description": [
                        "Use in patients who are opioid dependent may precipitate opioid withdrawal characterized by body aches, diarrhea, tachycardia, fever, runny nose, sneezing, piloerection, sweating, yawning, nausea or vomiting, nervousness, restlessness or irritability, shivering or trembling, abdominal cramps, weakness, and increased blood pressure ",
                        "In neonates, opioid withdrawal may be life-threatening if not recognized and properly treated and may include convulsions, excessive crying, and hyperactive reflexes",
                        "Abrupt postoperative reversal of opioid depression may result in nausea, vomiting, sweating, tremulousness, tachycardia, hypotension, hypertension, seizures, ventricular tachycardia and fibrillation, pulmonary edema, and cardiac arrest; these events have primarily occurred in patients who had preexisting cardiovascular disorders or received other drugs that may have similar adverse cardiovascular effects",
                        "Consider avoiding use in certain clinical settings (eg, postpartum period in neonates with known or suspected exposure to maternal opioid use) and using an alternant naloxone-containing product that can titrate to effect "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Precipitation of severe opioid withdrawal",
            "percent": null
        },
        {
            "name": "Increased blood pressure",
            "percent": null
        },
        {
            "name": "Musculoskeletal pain",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Nasal dryness",
            "percent": null
        },
        {
            "name": "Nasal edema",
            "percent": null
        },
        {
            "name": "Nasal congestion",
            "percent": null
        },
        {
            "name": "Nasal inflammation",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Asthenia",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "Headache",
            "percent": null
        },
        {
            "name": "Nasal discomfort",
            "percent": null
        },
        {
            "name": "Presyncope",
            "percent": null
        },
        {
            "name": "Nasal irritation",
            "percent": null
        },
        {
            "name": "Signs of nasal inflammation",
            "percent": null
        },
        {
            "name": "Nasal congestion",
            "percent": null
        },
        {
            "name": "Aggressive behavior upon abrupt reversal of an opioid overdose",
            "percent": null
        },
        {
            "name": "Constipation",
            "percent": null
        },
        {
            "name": "Toothache",
            "percent": null
        },
        {
            "name": "Muscle spasms",
            "percent": null
        },
        {
            "name": "Rhinalgia",
            "percent": null
        },
        {
            "name": "Xeroderma",
            "percent": null
        },
        {
            "name": "Hypotension",
            "percent": null
        },
        {
            "name": "Hypertension",
            "percent": null
        },
        {
            "name": "Ventricular tachycardia and fibrillation",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Pulmonary edema",
            "percent": null
        },
        {
            "name": "Cardiac arrest",
            "percent": null
        },
        {
            "name": "Death",
            "percent": null
        },
        {
            "name": "Coma",
            "percent": null
        },
        {
            "name": "Encephalopathy",
            "percent": null
        },
        {
            "name": "Agitation",
            "percent": null
        },
        {
            "name": "Withdrawal syndrome",
            "percent": null
        },
        {
            "name": "Vomiting",
            "percent": null
        },
        {
            "name": "Nonresponsive to stimuli",
            "percent": null
        },
        {
            "name": "Drug ineffective",
            "percent": null
        },
        {
            "name": "Agitation",
            "percent": null
        },
        {
            "name": "Somnolence",
            "percent": null
        },
        {
            "name": "Loss of consciousness",
            "percent": null
        }
    ]
}